- ISIN
- US00808Y3071
- CUSIP
- 00808Y307
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jan 2, 2001
Highlights
- EPS (TTM)
- -$24.20
- Gross Profit (TTM)
- -$547.23K
- EBITDA (TTM)
- -$11.01M
- Year Range
- $1.31 - $27.40
- ROA (TTM)
- -0.00%
- ROE (TTM)
- -0.00%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
AEMD Performance Chart
Aethlon Medical Inc (AEMD) is down 50.2% since the beginning of the year. At $1 per share, AEMD is trading 95.0% below its 52-week high of $27. Investors who bought $1,000 worth of AEMD shares 5 years ago would now be looking at an investment worth $0.
Loading charts...
Returns By Period
Aethlon Medical Inc (AEMD) has returned -50.18% so far this year and -91.27% over the past 12 months. Over the last ten years, AEMD has returned -66.26% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Aethlon Medical Inc
- 1D
- -26.98%
- 1M
- -37.27%
- YTD
- -50.18%
- 6M
- -52.08%
- 1Y
- -91.27%
- 3Y*
- -83.44%
- 5Y*
- -80.01%
- 10Y*
- -66.26%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
AEMD Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 2001, AEMD's average daily return is +0.14%, while the average monthly return is +0.16%. At this rate, an investment would double in approximately 36.1 years.
Historically, 38% of months were positive and 62% were negative. The best month was Jan 2020 with a return of +352.1%, while the worst month was May 2024 at -68.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.
On a daily basis, AEMD closed higher 36% of trading days. The best single day was Jun 9, 2021 with a return of +388.2%, while the worst single day was May 15, 2024 at -53.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.75% | -19.60% | 8.96% | 1.83% | -0.90% | -37.56% | -50.18% | ||||||
| 2025 | -18.62% | -26.03% | -30.85% | 6.42% | -1.84% | -59.89% | -0.83% | 57.14% | -59.96% | -29.74% | -15.59% | -37.61% | -95.97% |
| 2024 | -16.89% | -5.49% | -2.33% | -17.86% | -68.33% | 14.12% | -32.00% | 12.06% | 22.74% | -16.81% | 5.67% | 109.76% | -60.73% |
| 2023 | 110.60% | -16.09% | -21.41% | -0.18% | -20.46% | 18.51% | 1.83% | -24.97% | -17.89% | -35.78% | 31.03% | 15.26% | -20.48% |
| 2022 | -20.43% | -10.81% | 10.61% | -26.71% | 25.23% | -16.42% | -10.71% | -3.00% | -40.00% | -16.15% | -13.32% | -34.89% | -85.19% |
| 2021 | -6.88% | -4.35% | -7.73% | -10.34% | -4.40% | 182.76% | -0.41% | -24.08% | 3.76% | -6.99% | -32.31% | -23.46% | -24.70% |
Benchmark Metrics
Aethlon Medical Inc has an annualized alpha of 38.62%, beta of 0.39, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 02, 2001.
- This stock participated in 165.11% of S&P 500 Index downside but only -56.88% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.39 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 38.62%
- Beta
- 0.39
- R²
- 0.00
- Upside Capture
- -56.88%
- Downside Capture
- 165.11%
Return for Risk
Risk / Return Rank
AEMD ranks 11 for risk / return — in the bottom 11% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Aethlon Medical Inc (AEMD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AEMD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.60 | ||
| Sortino ratioReturn per unit of downside risk | -3.97 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.37 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 2.78 | -3.76 |
| Martin ratioReturn relative to average drawdown | -1.19 | 12.44 | -13.63 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Aethlon Medical Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aethlon Medical Inc was 100.00%, occurring on Jun 22, 2026. The portfolio has not yet recovered.
The current Aethlon Medical Inc drawdown is 100.00%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -100.00%Jun 2026 | 24y 7mo | — | 24y 7moNov 2001 - now |
Dot-com crash2000–2002 | -40.00%Apr 2001 | 2mo 15d | 5d | 2mo 20dFeb 2001 - Apr 2001 |
Dot-com crash2000–2002 | -35.71%Aug 2001 | 1mo 11d | 2mo 17d | 3mo 28dJul 2001 - Oct 2001 |
Dot-com crash2000–2002 | -25.00%Jan 2001 | 0s | 3d | 3dJan 2001 - Jan 2001 |
Dot-com crash2000–2002 | -16.67%May 2001 | 0s | 20d | 20dMay 2001 - Jun 2001 |
Drawdown Indicators
| AEMD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -93.70% | -9.10% | -84.60% |
Max Drawdown (3Y)Largest decline over 3 years | -99.62% | -18.90% | -80.72% |
Max Drawdown (5Y)Largest decline over 5 years | -99.97% | -25.43% | -74.54% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -33.92% | -66.08% |
Current DrawdownCurrent decline from peak | -100.00% | -1.80% | -98.20% |
Average DrawdownAverage peak-to-trough decline | -90.71% | -10.71% | -80.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 76.75% | 2.03% | +74.72% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Aethlon Medical Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Aethlon Medical Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with AEMD
Add Aethlon Medical Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with AEMD